Healthcare / Health Information ServicesToronto
$7.62
+0.14 (+1.87%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $14.2M · quality 71.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
48/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$482M
P/E
63.5x
↑EV/EBITDA
23.7x
↑ROE
2.3%
↑Gross Margin
80.4%
↑Debt/Equity
0.01
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+39.7%
FCF CAGR
+10.7%
FCF margin
7.2%
FCF / Net income
1.29x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $109.0M · net income $6.1M · FCF $7.9M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $109.0M | $109.0M | $68.6M | $52.5M | $40.0M |
| Net Income | $6.1M | $6.1M | $3.0M | $4.5M | $1.2M |
| EBITDA | $17.1M | $17.1M | $11.9M | $10.4M | $5.3M |
| EPS | 0.10 | 0.10 | 0.06 | 0.10 | 0.03 |
| Gross Margin | 80.4% | 80.4% | 80.9% | 81.5% | 82.4% |
| Operating Margin | 11.2% | 11.2% | 14.2% | 13.1% | 11.7% |
| Net Margin | 5.6% | 5.6% | 4.4% | 8.7% | 3.0% |
| Balance Sheet | |||||
| Debt/Equity | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 |
| Current Ratio | 2.26 | 2.26 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $7.9M | $7.9M | $14.2M | $20.2M | $5.8M |
| Returns | |||||
| ROE | 2.3% | 2.3% | 2.1% | 5.6% | 1.6% |
| Valuation | |||||
| P/E | 63.50 | 63.50 | 179.67 | 38.90 | 89.00 |
| EV/EBITDA | 23.71 | 23.71 | 41.43 | 14.29 | 18.49 |
| P/B | 1.73 | 1.73 | 3.79 | 2.21 | 1.51 |
| Growth & Yield | |||||
| Revenue Growth | 58.9% | 58.9% | 30.6% | 31.4% | — |
| EPS Growth | 66.7% | 66.7% | -40.0% | 233.3% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
89.1%
EPS terminal req.
$0.68
Spread vs growth
-22.4%
5Y implied EPS CAGR
52.3%
EPS terminal req.
$0.82
Spread vs growth
14.4%
10Y implied EPS CAGR
29.4%
EPS terminal req.
$1.32
Spread vs growth
37.3%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-24.6%
Start / end P/E
168.5x → 76.2x
EPS bridge
0.06 → 0.10
Residual
-36.5%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.